ITM Isotope Technologies Munich SE is gearing up to enter the US market with its radiopharmaceutical therapy, ITM-11 ...
2h
Jacobin on MSNYou’ve Already Paid for Overpriced Weight-Loss DrugsUS taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
With former Eli Lilly and Company CEO John Lechleiter, Crouch founded the Indiana Roundtable on Mental Health, a partnership with the Indianapolis Colts, Indiana Pacers, the Indiana Chamber, Lilly and ...
Hims & Hers Health ( HIMS -12.79%) stock took a tumble Thursday morning, falling 9.2% through 11:40 a.m. ET on some ...
Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli ...
Teladoc Health teams up with Eli Lilly's LillyDirect to improve Zepbound access, offering direct home delivery and comprehensive obesity care support.
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese people without diabetes and another one for people with diabetes.
England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results